Global Cell-free DNA Mutation Diagnostics Market 2025 by Company, Regions, Type and Application, Forecast to 2031
Description
According to our latest research, the global Cell-free DNA Mutation Diagnostics market size will reach USD 21560 million in 2031, growing at a CAGR of 14.6% over the analysis period.
Cell-free DNA Mutation Diagnostics is a cutting-edge diagnostic technique that analyzes cell-free DNA (cfDNA) in bodily fluids (typically blood or urine) to detect genetic mutations associated with diseases, especially cancer. cfDNA refers to DNA fragments that are released into the bloodstream when cells die or break down. This method provides a non-invasive alternative to traditional biopsy procedures for detecting genetic mutations, enabling early disease detection, monitoring, and personalized treatment planning.
This report is a detailed and comprehensive analysis for global Cell-free DNA Mutation Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cell-free DNA Mutation Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Cell-free DNA Mutation Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Cell-free DNA Mutation Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Cell-free DNA Mutation Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell-free DNA Mutation Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell-free DNA Mutation Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Natera, Guardant, Freenome Holdings, GRAIL, Exact Sciences Corporation, Foundation Medicine, Biocept, Thermo Fisher Scientific, Roche Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cell-free DNA Mutation Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Kits
Instruments
Services
Market segment by Application
Hoispital
Clinic
Laboratories
Others
Market segment by players, this report covers
Illumina
Natera
Guardant
Freenome Holdings
GRAIL
Exact Sciences Corporation
Foundation Medicine
Biocept
Thermo Fisher Scientific
Roche Diagnostics
Agilent Technologies
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings
Myriad Genetics
BillionToOne
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell-free DNA Mutation Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell-free DNA Mutation Diagnostics, with revenue, gross margin, and global market share of Cell-free DNA Mutation Diagnostics from 2020 to 2025.
Chapter 3, the Cell-free DNA Mutation Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cell-free DNA Mutation Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell-free DNA Mutation Diagnostics.
Chapter 13, to describe Cell-free DNA Mutation Diagnostics research findings and conclusion.
Cell-free DNA Mutation Diagnostics is a cutting-edge diagnostic technique that analyzes cell-free DNA (cfDNA) in bodily fluids (typically blood or urine) to detect genetic mutations associated with diseases, especially cancer. cfDNA refers to DNA fragments that are released into the bloodstream when cells die or break down. This method provides a non-invasive alternative to traditional biopsy procedures for detecting genetic mutations, enabling early disease detection, monitoring, and personalized treatment planning.
This report is a detailed and comprehensive analysis for global Cell-free DNA Mutation Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cell-free DNA Mutation Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Cell-free DNA Mutation Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Cell-free DNA Mutation Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Cell-free DNA Mutation Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell-free DNA Mutation Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell-free DNA Mutation Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Natera, Guardant, Freenome Holdings, GRAIL, Exact Sciences Corporation, Foundation Medicine, Biocept, Thermo Fisher Scientific, Roche Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cell-free DNA Mutation Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Kits
Instruments
Services
Market segment by Application
Hoispital
Clinic
Laboratories
Others
Market segment by players, this report covers
Illumina
Natera
Guardant
Freenome Holdings
GRAIL
Exact Sciences Corporation
Foundation Medicine
Biocept
Thermo Fisher Scientific
Roche Diagnostics
Agilent Technologies
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings
Myriad Genetics
BillionToOne
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell-free DNA Mutation Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell-free DNA Mutation Diagnostics, with revenue, gross margin, and global market share of Cell-free DNA Mutation Diagnostics from 2020 to 2025.
Chapter 3, the Cell-free DNA Mutation Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cell-free DNA Mutation Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell-free DNA Mutation Diagnostics.
Chapter 13, to describe Cell-free DNA Mutation Diagnostics research findings and conclusion.
Table of Contents
114 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
